7.5 | | SPAG6 | 'trichostatin A; 500 nanomolar' vs 'control' | compound | Transcription profiling by high throughput sequencing of human aortic endothelial cell treated with TSA |
7 | | SPAG6 | 'suberoylanilide hydroxamic acid' vs 'control' | compound | Vascular histone deacetylation by pharmacological HDAC inhibition [SAHA, RNA-seq] |
6.2 | | SPAG6 | 'progenitor cell of endocrine pancreas' vs 'definitive endoderm cell' in 'GATA6 R456C/+; Patient A" | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
6 | | SPAG6 | 'valproic acid; 15 millimolar' vs 'control' at '2 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
5.7 | | SPAG6 | 'valproic acid; 15 millimolar' vs 'control' at '3 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
5.6 | | SPAG6 | 'posterior fossa group B ependymoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
5.6 | | SPAG6 | 'apical radial glial cell' vs 'neuron' | cell type | Transcription profiling by high throughput sequencing of the developing human cortex |
-5.6 | | SPAG6 | 'gestational week 11 to 13' vs 'adult' in 'normal' | developmental stage, phenotype | Comparison of global gene expression profiles of microdissected human foetal Leydig cells with their normal and hyperplastic adult equivalents |
-4.8 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 2' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-4.7 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 3.2' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
4.7 | | SPAG6 | 'valproic acid; 15 millimolar' vs 'control' at '1 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
4.7 | | SPAG6 | 'poly(I:C); 25 microgram per milliliter' vs 'none' in 'none; none' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
4.5 | | SPAG6 | 'posterior fossa group A ependymoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-4.3 | | SPAG6 | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-4.3 | | SPAG6 | 'Mycobacterium tuberculosis' vs 'none' in 'infant' | developmental stage, infect | Multifaceted dysfunction of infant airway macrophages in response to Mycobacterium tuberculosis |
4.2 | | SPAG6 | 'ependymoma' vs 'normal' | disease | Expression data from human brain tumors and human normal brain |
-4.1 | | SPAG6 | 'colorectal carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
4.1 | | SPAG6 | 'supratentorial ependymoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
4.1 | | SPAG6 | '28 day' vs '0 day' | time | Transcription profiling of human airway epithelial cells cultured at an air-liquid interface (ALI) and sampled at multiple time points to examine mucociliary differentiation |
-4 | | SPAG6 | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'definitive endoderm cell' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
4 | | SPAG6 | '21 day' vs '0 day' | time | Transcription profiling of human airway epithelial cells cultured at an air-liquid interface (ALI) and sampled at multiple time points to examine mucociliary differentiation |
-4 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 2' vs 'ejaculatory azoospermia; Johnsen score count 7' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-4 | | SPAG6 | 'MTF2 homozygous knockout' vs 'wild type' | phenotype | RNA-seq of human near-haploid cell line HAP1 with CRISPR-edited frameshift mutations |
3.9 | | SPAG6 | 'normal lung epithelia the third closest to the tumor; normal airway epithelia' vs '; normal' | biopsy site, disease | Gene expression profiling of the adjacent airway field cancerization in early stage NSCLC |
3.9 | | SPAG6 | 'normal lung epithelia the second farthest from the tumor; normal airway epithelia' vs '; normal' | biopsy site, disease | Gene expression profiling of the adjacent airway field cancerization in early stage NSCLC |
-3.9 | | SPAG6 | 'myelodysplastic syndrome; SF3B1 mutated K700E' vs 'normal' | disease, genotype | RNA-seq of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls |
-3.8 | | SPAG6 | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'progenitor cell of endocrine pancreas' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
3.8 | | SPAG6 | 'normal lung epithelia the second closest to the tumor; normal airway epithelia' vs '; normal' | biopsy site, disease | Gene expression profiling of the adjacent airway field cancerization in early stage NSCLC |
3.8 | | SPAG6 | 'normal lung epithelia farthest from the tumor; normal airway epithelia' vs '; normal' | biopsy site, disease | Gene expression profiling of the adjacent airway field cancerization in early stage NSCLC |
3.8 | | SPAG6 | 'erythroleukemia; ZRSR2 shRNA' vs 'normal' | disease, genotype | RNA-seq of bone marrow from patients with myelodysplastic syndrome |
3.8 | | SPAG6 | '14 day' vs '0 day' | time | Transcription profiling of human airway epithelial cells cultured at an air-liquid interface (ALI) and sampled at multiple time points to examine mucociliary differentiation |
3.7 | | SPAG6 | 'normal lung epithelia closest to the tumor; normal airway epithelia' vs '; normal' | biopsy site, disease | Gene expression profiling of the adjacent airway field cancerization in early stage NSCLC |
-3.7 | | SPAG6 | 'teratozoospermia' vs 'normospermic' | disease | Transcription profiling by array of human sperm from normospermic and teratozoospermic individuals |
-3.7 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 2' vs 'ejaculatory azoospermia; Johnsen score count 8' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
3.7 | | SPAG6 | '10 day' vs '0 day' | time | Transcription profiling of human airway epithelial cells cultured at an air-liquid interface (ALI) and sampled at multiple time points to examine mucociliary differentiation |
3.6 | | SPAG6 | 'ETV6-RUNX1 shRNA 2' vs 'control shRNA' at '0 hour' | RNA interference, time | RNA-seq following shRNA-mediated knock-down of ETV6-RUNX1 in the B-ALL cell line Reh |
3.5 | | SPAG6 | 'Human gammaherpesvirus 4' at '14 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-3.5 | | SPAG6 | 'squamous cell carcinoma' vs 'normal' | block, disease | RNA-seq of a panel of non-melanoma skin cancer lesions |
3.4 | | SPAG6 | 'replicatively senescent; grown until growth arrest' vs 'spontaneously immortal cells; control' | phenotype, treatment | Pathway Profiling of Replicative and Induced Senescence |
3.2 | | SPAG6 | 'SNCA overexpression' vs 'wild type genotype' | genotype | RNA-seq of human midbrain organoid models of Parkinson's Disease |
-3.2 | | SPAG6 | 'Influenza A virus (A/California/07-00001/2009(H1N1))' vs 'none' in 'poly(I:C); 25 microgram per milliliter; none' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
3.2 | | SPAG6 | 'ssON; 0.5 micromolar' vs 'none' in 'none; none' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
3.1 | | SPAG6 | '8 day' vs '0 day' | time | Transcription profiling of human airway epithelial cells cultured at an air-liquid interface (ALI) and sampled at multiple time points to examine mucociliary differentiation |
3 | | SPAG6 | 'overexpression of Halo-RelA' vs 'control' | phenotype | Transcription profiling by high throughput sequencing of HEK293 cells expressing Halo-RelA, Halo-NFkB1, or Halo tag alone |
-3 | | SPAG6 | 'nasopharyngeal carcinoma' vs 'normal' | disease | Transcription profiling by array of human nasopharyngeal carcinoma patients |
3 | | SPAG6 | 'P-bodies (cytosolic RNP granules)' vs 'pre-sorted fraction' | fraction | RNA-Seq of purified P-bodies from HEK293 cells |
3 | | SPAG6 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Next Generation Sequencing Identification of HBV-MLL4 integration and its molecular basis in Chinese hepatocellular carcinoma |
2.9 | | SPAG6 | 'HES1 homozygous knockout' vs 'wild type genotype' | genotype | RNA-seq of Human Embryonic Stem Cell derived pancreas progenitor differentiation, Day 13 of wildtype, HES1-/-, NEUROG3-/- and HES1-/-NEUROG3-/- genotypes |
-2.9 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 5' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-2.9 | | SPAG6 | 'K-562; chronic myelogenous (blast crisis) leukemia; P10' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
2.9 | | SPAG6 | 'induced pluripotent stem cell' vs 'fibroblast of dermis' in 'normal' | cell type, disease | Klinefelter syndrome derived hiPSCs show similar XCI behavior as female hPSCs |
2.9 | | SPAG6 | 'Human gammaherpesvirus 4' at '8 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
2.8 | | SPAG6 | 'CD3/CD28 beads' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
-2.8 | | SPAG6 | 'KLF17 overexpression' vs 'wild type' at '5 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
-2.7 | | SPAG6 | 'pancreatic adenocarcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
2.7 | | SPAG6 | 'MCT8[P321L]' vs 'wild type genotype' in 'derived neural cell; T3; 100 nanomolar' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
-2.7 | | SPAG6 | 'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
-2.7 | | SPAG6 | 'Neurobasal medium' vs 'DMEM/F12 with glutamax' | growth condition | RNA sequencing of human iPSC-derived brain microvascular endothelial cells. |
-2.6 | | SPAG6 | 'hepatobiliary carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
2.6 | | SPAG6 | 'correction to MCT8[wt]' vs 'wild type genotype' in 'derived neural cell; T3; 100 nanomolar' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
-2.6 | | SPAG6 | 'H1N1 swine influenza virus' vs 'none' at '48 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
2.5 | | SPAG6 | 'peripheral zone of prostate' vs 'transition zone of prostate' in 'benign' | sampling site, tumor grading | Transcriptional differences between the peripheral and the transcription zone of the prostate |
2.5 | | SPAG6 | 'T3; 100 nanomolar' vs 'none' in 'derived neural cell; MCT8[P321L]' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
-2.5 | | SPAG6 | 'adenocarcinoma' vs 'normal tissue adjacent to adenocarcinoma' | histology | Gene expression analysis of lung cancer samples and healthy controls |
2.5 | | SPAG6 | 'Influenza A virus (A/California/07-00001/2009(H1N1))' vs 'none' in 'none; none' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
2.4 | | SPAG6 | 'valproic acid 4 millimolar' vs 'none' | compound, dose | Transcription profiling by array of HUVEC cells after treatment with valproic acid |
2.4 | | SPAG6 | 'West Nile Virus protein E domain DIII' at '6 hour' vs 'none' at '0 hour' | stimulus, time | Transcriptome analysis of human brain microvascular endothelial cells response to interactive DIII domain of protein E of WNV and interactive DIII domain of protein E of TBEV using RNA-seq |
-2.3 | | SPAG6 | 'Mycobacterium tuberculosis' vs 'none' in 'adult' | developmental stage, infect | Multifaceted dysfunction of infant airway macrophages in response to Mycobacterium tuberculosis |
-2.2 | | SPAG6 | 'non-small cell lung carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-2.2 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 5' vs 'ejaculatory azoospermia; Johnsen score count 7' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-2.1 | | SPAG6 | 'Influenza A virus (A/California/07-00001/2009(H1N1))' vs 'none' in 'poly(I:C); 25 microgram per milliliter; ssON; 0.5 micromolar' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
2 | | SPAG6 | ' neural stem cell' vs 'induced pluripotent stem cell' in 'Ataxia-telangiectasia' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
2 | | SPAG6 | '11 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
-2 | | SPAG6 | 'H1N1 swine influenza virus' vs 'none' at '36 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-2 | | SPAG6 | 'CA-PDGFRA + sh-p53' vs 'mock' | genotype | Human ESC-based modeling of pediatric gliomas by K27M mutation in histone H3.3 variant |
-1.9 | | SPAG6 | 'smoker; lung adenocarcinoma' vs 'never smoked; normal' | clinical information, disease | Gene expression profiling of lung adenocarcinomas and normal lung tissue |
-1.9 | | SPAG6 | 'contrast-enhancing core; glioma' vs 'normal' | biopsy site, disease | Transcription profiling by high throughput sequencing in the margins of glioblastoma |
1.9 | | SPAG6 | 'LBH589 (panobinostat)' vs 'DMSO' in 'H295R' | cell line, compound | Transcription profiling by array of three human cancer cell lines (H295R, HeLa and MCF-7her2) with and without treatment with histone deacetylase inhibitor LBH589 (panobinostat) |
-1.9 | | SPAG6 | 'familial hemophagocytic lymphohistiocytosis 5' vs 'normal' | disease | RNAseq on PBMC of three patients with Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL5) and three age and sex-matched controls |
-1.9 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 2' vs 'ejaculatory azoospermia; Johnsen score count 5' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
1.9 | | SPAG6 | 'interferon alpha; 1000 international units per millliter' vs 'none' in 'not applicable; CD34-positive, CD38-negative hematopoietic stem cell' | cell line, cell type, stimulus | Transcriptome analysis of HSPC, THP1 and K562 cells under IFNɑ treatment |
-1.8 | | SPAG6 | 'cells permissive for late gene expression of HPV-16' vs 'control' | phenotype | Whole genome analysis of cells permissive for late gene expression of HPV-16 |
1.8 | | SPAG6 | 'blood alcohol content 0.02%declining' vs 'control' in 'time point 5' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.8 | | SPAG6 | 'GATA6 c.618_619insTGCA/+' vs 'wild type genotype' in 'H9; definitive endoderm cell' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-1.8 | | SPAG6 | 'poly(I:C); 25 microgram per milliliter' vs 'none' in 'Influenza A virus (A/California/07-00001/2009(H1N1)); ssON; 0.5 micromolar' | compound, infect, stimulus | RNA-seq of H1N1 infected monocyte-derived dendritic cells (MoDC), stimulated with single-stranded oligonucleotides (ssON) and/or Poly I:C. |
-1.8 | | SPAG6 | 'ejaculatory azoospermia; Johnsen score count 3.2' vs 'ejaculatory azoospermia; Johnsen score count 5' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.7 | | SPAG6 | 'K-562; chronic myelogenous (blast crisis) leukemia; P04' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.7 | | SPAG6 | 'after androgen ablation therapy' vs 'before androgen ablation therapy' | treatment | Transcription profiling by high throughput sequencing of advanced prostate cancer treated with androgen-deprivation therapy |
1.7 | | SPAG6 | '5-Aza-deoxycytidine' vs 'none' in 'TC71' | cell line, compound | Pharmacologic Inhibition of Epigenetic Modification Reveals Targets of Aberrant Promoter Methylation in Ewing Sarcoma |
1.6 | | SPAG6 | 'blood alcohol content 0.08%' vs 'control' in 'time point 3' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.6 | | SPAG6 | 'cigarette smoke' vs 'control' at '40 day' | stimulus, time | Repeated exposure and switching study of cigarette smoke and next generation tobacco product using 3D human bronchial epithelial cells |
1.6 | | SPAG6 | 'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-1.6 | | SPAG6 | 'CRISPR-Cas9 induced GNRH1 reporter; 27 day' vs 'wild type genotype; 20 day' | genotype, stimulus, time | RNA-Seq of GNRH1 neurons differentiated from human pluripotent stem cells |
-1.6 | | SPAG6 | 'GATA6 c.611_614delACCT/c.611_614delACCT' vs 'wild type genotype' in 'H9; definitive endoderm cell' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-1.6 | | SPAG6 | 'Severe acute respiratory syndrome-related coronavirus' vs 'none' at '96 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
1.5 | | SPAG6 | 'blood alcohol content 0%' vs 'control' in 'time point 1' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.5 | | SPAG6 | 'blood alcohol content 0.04%declining' vs 'control' in 'time point 4' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.5 | | SPAG6 | 'autism' vs 'normal' | disease | Transcriptomic analysis of autistic brain reveals convergent molecular pathology [high-throughput sequence data] |
-1.5 | | SPAG6 | 'tumor tissue' vs 'non-malignant tissue' | sampling site | RNA-seq of 199 non-small cell lung carcinoma patients and 19 paired normal lung tissues |
1.5 | | SPAG6 | '1 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
-1.5 | | SPAG6 | 'KLF17 overexpression' vs 'wild type phenotype' at '5 day' | phenotype, time | RNA-seq of hESCs overexpressing inducible KLF17 versus uninduced controls. |
1.4 | | SPAG6 | 'group 4 medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-1.4 | | SPAG6 | 'H1N1 swine influenza virus' vs 'none' at '12 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-1.4 | | SPAG6 | 'glioblastoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1.4 | | SPAG6 | 'non-triple-negative breast cancer; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
1.4 | | SPAG6 | 'group 3 medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
1.3 | | SPAG6 | 'blood alcohol content 0.04%rising' vs 'control' in 'time point 2' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.3 | | SPAG6 | 'epithelial-to-mesenchymal transition' vs 'normal' | phenotype | Gene expression from H69M versus H69 SCLC cell lines |
1.3 | | SPAG6 | 'NKAES-derived NK cells' vs 'primary human NK cells' in 'none' | clinical history, compound | Transcription profiling by array of human natural killer cells |
-1.3 | | SPAG6 | 'Astrocytoma, Pilocytic' vs 'normal' | disease | Expression data from human brain tumors and human normal brain |
-1.3 | | SPAG6 | 'H1N1 swine influenza virus' vs 'none' at '24 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-1.3 | | SPAG6 | 'hyperglycemic condition' vs 'non-diabetic condition' | clinical information | Transcription profiling by array of human pancreatic beta cells transplanted into mice |
1.3 | | SPAG6 | '5-Aza-deoxycytidine' vs 'none' in 'A4573' | cell line, compound | Pharmacologic Inhibition of Epigenetic Modification Reveals Targets of Aberrant Promoter Methylation in Ewing Sarcoma |
-1.2 | | SPAG6 | 'psoriasis; lesional skin' vs 'normal; normal' | disease, phenotype | Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms |
-1.2 | | SPAG6 | 'human rhinovirus 16' vs 'vehicle' in 'asthma' | disease, infect | Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhinovirus |
-1.2 | | SPAG6 | 'K-562; chronic myelogenous (blast crisis) leukemia; P01' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.2 | | SPAG6 | 'pilocytic astrocytoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-1.2 | | SPAG6 | 'synthetic recombinant bat SARS-like coronavirus' vs 'none' at '60 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-1.2 | | SPAG6 | 'Severe acute respiratory syndrome-related coronavirus dORF6' vs 'none' at '60 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
1.2 | | SPAG6 | 'ML792; 400 nanomolar; 48 hour' vs 'dimethyl sulfoxide; 48 hour' | compound, time | Influence of SUMOylation on transcriptional signature of hIPSCs (ChiPS4) assessed by time-resolved RNA-seq in response to ML792 treatment |
-1.2 | | SPAG6 | 'cigarette smoke_stop exposure' vs 'control' at '40 day' | stimulus, time | Repeated exposure and switching study of cigarette smoke and next generation tobacco product using 3D human bronchial epithelial cells |
-1.1 | | SPAG6 | 'primary tumor' vs 'adjacent normal tissue' | clinical information | Transcription profiling by array of human non-small cell lung cancer tissue from female non-smokers |
-1.1 | | SPAG6 | 'glioblastoma' vs 'normal' | disease | Expression data from human brain tumors and human normal brain |
1.1 | | SPAG6 | '16 to 24 weeks post ovulation' vs 'adult' in 'normal' | developmental stage, disease | Comparison of gene expression profiling of human lung at four developmental stages and lung adenocarcioma |
-1.1 | | SPAG6 | 'non small cell lung carcinoma neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | RNA profiling of non-small cell lung cancer |
-1.1 | | SPAG6 | 'tumor tissue' vs 'adjacent non-tumor tissue' | sampling site | RNA-seq of prostate cancer and adjacent normal tissues from 14 patients |
1 | | SPAG6 | 'ETV5 shRNA' vs 'control shRNA' in 'tumour growth in mouse xenograft' | RNA interference, growth condition | RNA-seq of SH-SY5Y NB cells stably transduced with shETV5 compared to parental cells, cell line samples and samples of xenografted tumors |
-1 | | SPAG6 | 'lesion' vs 'normal tissue adjacent to lesion' in '1 week' | sampling site, time | RNA-sequencing of the mRNA transcriptome in lesional and non-lesional skin, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept |
1 | | SPAG6 | 'Ataxia-telangiectasia' vs 'normal' | disease | Ataxia-telangiectasia cerebellar cortex expression |
1 | | SPAG6 | 'differentiated; hAKPC-P' vs 'undifferentiated; hIPod' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-1 | | SPAG6 | 'Zaire ebolavirus lacking the VP30 gene' vs 'mock' at '18 hour' | infect, time | Human U937 cell transcriptome response to Zaire Ebola virus wild-type in the delta-VP30 background and delta-mucin virus |
1 | | SPAG6 | 'ZNA; 30 micromolar' vs 'DMSO' at '12 hour' | compound, time | RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA |
-1 | | SPAG6 | 'LMP1' vs 'empty vector' | genotype | Transcription profiling by array of human LMP1 transfected CD10-positive germinal center B cells |
-1 | | SPAG6 | 'smoker; lung adenocarcinoma' vs 'never smoked; lung adenocarcinoma' | clinical information, disease | Gene expression profiling of lung adenocarcinomas and normal lung tissue |
-1 | | SPAG6 | 'synthetic recombinant bat SARS-like coronavirus' vs 'none' at '12 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-1 | | SPAG6 | 'Severe acute respiratory syndrome-related coronavirus dORF6' vs 'none' at '72 hour' | infect, time | SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
-1 | | SPAG6 | 'never smoked; lung adenocarcinoma' vs 'never smoked; normal' | clinical information, disease | Gene expression profiling of lung adenocarcinomas and normal lung tissue |
-1 | | SPAG6 | 'colon sessile serrated adenoma/polyp' vs 'normal' | disease | RNA-seq of 21 sessile serrated colon adenoma/polyps, 10 hyperplastic polyps, 10 adenomas, 21 uninvolved colon and 20 control colon specimens |
-1 | | SPAG6 | 'adult high grade glioma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
